Holen Sie sich die Stockscreener-App
4.74
3.04%
0.14
Schlusskurs vom Vortag:
$4.60
Offen:
$4.6719
24-Stunden-Volumen:
41,870
Relative Volume:
0.27
Marktkapitalisierung:
$3.19M
Einnahmen:
$49,300
Nettoeinkommen (Verlust:
$-6.27M
KGV:
-0.5215
EPS:
-9.09
Netto-Cashflow:
$-5.38M
1W Leistung:
-12.06%
1M Leistung:
-33.89%
6M Leistung:
-38.32%
1J Leistung:
+23.63%
1-Tages-Spanne:
$4.60
$4.87
1-Wochen-Bereich:
$4.32
$5.4655
52-Wochen-Spanne:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Firmenname
Aclarion Inc
Sektor
Branche
Telefon
833 275 2266
Adresse
8181 ARISTA PLACE, BROOMFIELD
Vergleichen Sie ACON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
4.75 | 3.09M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
219.41 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.86 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.45 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.79 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.38 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Aclarion Inc Aktie (ACON) Neueste Nachrichten
Aclarion announces revised reverse stock split details - MSN
Aclarion (NASDAQ:ACON) Rating Increased to Hold at Wall Street Zen - Defense World
Aclarion, Inc. (NASDAQ:ACON) Sees Large Increase in Short Interest - Defense World
What margin trends mean for Aclarion Inc. stock2025 Risk Factors & High Conviction Buy Zone Picks - Улправда
Is Aclarion Inc. stock a smart buy before Fed meeting2025 Fundamental Recap & Reliable Breakout Forecasts - Улправда
Trading Action: Why Aclarion Inc. stock appeals to dividend seekersMarket Risk Report & Daily Growth Stock Investment Tips - Улправда
Is Aclarion Inc. stock cheap at current valuationPortfolio Value Summary & Growth-Oriented Investment Plans - Улправда
Retail Trends: Why Aclarion Inc. stock is seen as undervaluedShare Buyback & Community Consensus Picks - Улправда
Can Aclarion Inc. stock hit record highs again2025 Support & Resistance & Weekly Top Stock Performers List - Улправда
How Aclarion Inc. Equity Warrant stock benefits from global expansionGap Up & Long-Term Safe Investment Plans - Улправда
Will Aclarion Inc. Equity Warrant stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Fund Flows: What margin trends mean for Aclarion Inc. stockMarket Performance Summary & Weekly Consistent Profit Watchlists - Улправда
Why Aclarion Inc. stock is seen as undervaluedPortfolio Risk Summary & High Conviction Buy Zone Alerts - Улправда
Is Aclarion Inc. Equity Warrant stock a safe haven asset2025 Investor Takeaways & Target Return Focused Stock Picks - DonanımHaber
Sell Signal: What margin trends mean for Aclarion Inc. stock2025 Trading Volume Trends & Weekly Hot Stock Watchlists - Улправда
Why Aclarion Inc. stock appeals to dividend seekersJuly 2025 Pullbacks & Stepwise Entry and Exit Trade Signals - Улправда
Growth Value: What makes Aclarion Inc. (IT20) stock appealing to growth investorsWeekly Trade Review & Technical Analysis for Trade Confirmation - Улправда
Aclarion Earnings Notes - Trefis
Nasdaq Moves: Will ATLCP stock continue upward momentumWeekly Stock Summary & Daily Risk Controlled Trade Plans - moha.gov.vn
Ramsay Health Care (OTCMKTS:RMYHY) vs. Aclarion (NASDAQ:ACON) Financial Review - Defense World
What drives Aclarion Inc stock priceReal Estate Investment Trusts & These 3 Stocks Could Change Your Portfolio - earlytimes.in
Aclarion shares move higher after Nociscan highlighted in spine surgery journal - MSN
Aclarion announces publication of Nociscan article in pain issue of IJSS - MSN
Aclarion (ACON) Price Target Increased by 15.00% to 23.46 - Nasdaq
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) - Orthopedics This Week
Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Aclarion Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria
Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser
Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser
How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser
Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative
Aclarion stock rises after feature in special pain issue of spine journal By Investing.com - Investing.com South Africa
Aclarion stock rises after feature in special pain issue of spine journal - Investing.com Canada
Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com
ACON FinancialsIncome Statement - Quiver Quantitative
Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative
Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan
Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser
Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser
Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser
Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com
Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph
Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks
Finanzdaten der Aclarion Inc-Aktie (ACON)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.08%
1.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):